At the 1-month follow-up, tumor marker tests revealed an AFP level of 1,687.8 ng/ml (reference range: 0.0–2,000 ng/ml) and a NSE level of 33.8 ng/ml (reference range: 21–39.2 ng/ml). Here, ENO2 is linked to neoplasm.